Articles in the press
Reducing Risk, Speeding Development — a CDMO Model Including GCP-sponsorship to Better Meet the Needs of Pharma Companies
Pharmaceutical companies are under mounting pressure to develop more user-friendly oral dosage forms. Faced with fierce market competition, they’re also demanding more CDMO support than ever. Can a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate the route to a market-ready product? View this Q&A with Drug Development & Delivery.
Infertility is declining throughout the industrialized world. But as people turn to fertility supplements for a solution, they’re met with inconvenient products. To better support consumers, supplement companies must provide science-backed formulations that are convenient, enjoyable to take long-term, and tailored to the nutritional needs of each sex. However, several manufacturing challenges can complicate the path to success. Article published with NutraIngredients.